报错 · 内容有误？请告诉我们。
Filing Date
2026-10-29
Accepted
2026-10-29 17:28:13
Documents
15
Period of Report
2026-10-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
Mailing Address 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608 (510) 318-9098
Estrella Immunopharma, Inc. (Filer) CIK: 0001844417 (see all company filings)
EIN.: 861314502 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40608 | Film No.: 261502984
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov